# VYEPTI
> **BLA761119** · Biologics License Application · Sponsor: Lundbeck Seattle BioPharmaceuticals, Inc. · Approved 2020-02-21
## Drug
- **FDA Application Number:** BLA761119
- **Application type:** Biologics License Application
- **Brand name:** VYEPTI
- **Generic name:** EPTINEZUMAB-JJMR
- **Active ingredients:** EPTINEZUMAB-JJMR
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** Lundbeck Seattle BioPharmaceuticals, Inc.
- **Manufacturer:** Lundbeck Pharmaceuticals LLC
- **First approval:** 2020-02-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761119)
---
*AI Analytics · CC0 1.0*